Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers. Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
| Website | https://corium.com/ |
| Ticker | NASDAQ:CORI |
| Revenue | $148.2 million |
| Employees | 450 (109 on RocketReach) |
| Founded | 1999 |
| Address | 4558 50th Street SE, Grand Rapids, Michigan 49512, US |
| Phone | +1 650-298-8255 |
| Technologies |
JavaScript
,
HTML
,
Font Awesome
+16 more
(view full list)
|
| Industry | Pharmaceuticals, Biotechnology, Science and Engineering, Health Care, Pharmaceutical |
| Web Rank | 17 Million |
| Keywords | Biopharmaceutical, Biotechnology, Cns Therapeutics, Central Nervous System, Drug Development, Neurological Disorders, Pharmaceutical Research, Treatment Options, Drug Commercialization, Innovative Therapies, Medicine, Patient Care, Prescription Drugs, Clinical Trials, Brain Health, Mental Health, Clinical Stage, Health |
| Competitors | Pharmathen, Sorrento Therapeutics, Inc., Acorda Therapeutics, Inc., Acelity, Novartis, GSK, Revance, Hikma Pharmaceuticals, Akcea Therapeutics, Amgen +47 more (view full list) |
Looking for a particular Corium, Inc. employee's phone or email?
The Corium, Inc. annual revenue was $148.2 million in 2026.
Logan Derck is the CFO of Corium, Inc..
109 people are employed at Corium, Inc..
Corium, Inc. is based in Grand Rapids, Michigan.